======= IMPDH1 ======= == Gene Information == * **Official Symbol**: IMPDH1 * **Official Name**: inosine monophosphate dehydrogenase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3614|3614]] * **UniProt**: [[https://www.uniprot.org/uniprot/P20839|P20839]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IMPDH1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IMPDH1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/146690|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene acts as a homotetramer to regulate cell growth. The encoded protein is an enzyme that catalyzes the synthesis of xanthine monophosphate (XMP) from inosine-5'-monophosphate (IMP). This is the rate-limiting step in the de novo synthesis of guanine nucleotides. Defects in this gene are a cause of retinitis pigmentosa type 10 (RP10). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]. * **UniProt Summary**: N/A |NMO| |FMN dh| |IMPDH| |CBS| |IMP dehydrogenase activity| |GMP biosynthetic process| |GTP biosynthetic process| |guanosine-containing compound biosynthetic process| |GMP metabolic process| |purine ribonucleoside monophosphate biosynthetic process| |purine nucleoside monophosphate biosynthetic process| |purine ribonucleoside biosynthetic process| |ribonucleoside biosynthetic process| |purine nucleoside biosynthetic process| |GTP metabolic process| |ribonucleoside monophosphate biosynthetic process| |purine ribonucleoside monophosphate metabolic process| |purine nucleoside monophosphate metabolic process| |nucleoside biosynthetic process| |guanosine-containing compound metabolic process| |glycosyl compound biosynthetic process| |nucleoside monophosphate biosynthetic process| |purine ribonucleoside triphosphate biosynthetic process| |purine nucleoside triphosphate biosynthetic process| |ribonucleoside triphosphate biosynthetic process| |ribonucleoside monophosphate metabolic process| |purine ribonucleoside triphosphate metabolic process| |purine ribonucleoside metabolic process| |nucleotide binding| |nucleoside triphosphate biosynthetic process| |purine nucleoside metabolic process| |ribonucleoside triphosphate metabolic process| |purine nucleoside triphosphate metabolic process| |nucleoside monophosphate metabolic process| |ribonucleoside metabolic process| |lymphocyte proliferation| |mononuclear cell proliferation| |azurophil granule lumen| |nucleoside triphosphate metabolic process| |leukocyte proliferation| |nucleobase-containing small molecule biosynthetic process| |nucleoside metabolic process| |secretory granule lumen| |ficolin-1-rich granule lumen| |glycosyl compound metabolic process| |purine ribonucleotide biosynthetic process| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |nucleic acid binding| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |lymphocyte activation| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |cell population proliferation| |myeloid leukocyte activation| |small molecule biosynthetic process| |carbohydrate derivative biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |organophosphate metabolic process| |leukocyte activation| |oxidation-reduction process| |secretion by cell| |carbohydrate derivative metabolic process| |export from cell| |cell activation| |immune effector process| |nucleobase-containing compound biosynthetic process| |secretion| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |RNA binding| |organonitrogen compound biosynthetic process| |DNA binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8850 * **Expression level (log2 read counts)**: 6.73 {{:chemogenomics:nalm6 dist.png?nolink |}}